SERPINA1 and alpha 1-antitrypsin deficiency: Apart from the most common pathogenic changes (resulting in PI*Z or PI*S AAT protein variants), there is a steady increase in the number of rare and new molecular variants (mostly SNVs) of unknown significance reported in SERPINA1 in relation to AATD phenotype, which demand thorough characterization and clinical interpretation.